Please Wait.....
Report
United States Women Health Laboratory Testing Market By Hereditary Cancer (Cervical Cancer, Ovarian Cancer, Breast Cancer), By Reproductive Health and Infectious Diseases (CT/NG Testing, Preimplantation Genetic Testing (PGT), Herpes Simplex Virus (HSV), Hepatitis, Sexually Transmitted Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, HPV Testing), By Prenatal Screening and Diagnostic Testing (Non-Invasive Prenatal Testing (NIPT), Maternal Serum Screening (MSS), Prenatal Diagnostic Testing), By Region, Competition Forecast & Opportunities, 2018-2028
Market Report I 2023-07-01 I 75 Pages I TechSci Research
United States Women Health Laboratory Testing Market is expected to grow at an impressive rate during the forecast period, 2024-2028. The major factors include the increasing prevalence of chronic diseases, trauma, anemia, myeloma, lymphoma, leukemia, etc., rising awareness regarding women's health-related tests, rising cases of aneuploidies, and medical advancement. The rising prevalence of cancer among the women population has significantly created new prospects for the growth of the United States Women Health Laboratory Testing Market. According to Global Cancer Observatory, in 2020, around 1 0,55,117 new cancer cases were reported in the United States.
Additionally, the other factor includes the increasing investments in the healthcare sector, the major involvement of market players, and the increase in the number of funding activities. Various initiatives and awareness programs are taken by government or private organizations to raise awareness about diseases and treatments, as well as information about the availability of more advanced technologies and procedures at healthcare facilities.
Prevalence of Chronic diseases
The prevalence of chronic diseases like cardiovascular diseases, surgeries, trauma, and injuries either caused due to road accidents or any other accidental or non-accidental reasons are resulting in the growth of the market. The main cause of the increasing demand for laboratory testing procedures is increased health issues in women and the demand for the treatment of various severe diseases like cancer. According to the American Cancer Society, more than 1.8 million people were diagnosed with cancer in 2020. For instance, an estimated 1,519,907 people in the United States are suffering from leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPNs). Additionally, in terms of health, women health varies from men in distinctive ways. Therefore, timely diagnosis/testing of a disease is important for getting management and treatment for the disease. Also, the significant increase in the prevalence of cancer and certain infectious diseases, such as sexually transmitted diseases, immunodeficiency virus (HIV), Hepatitis, Syphilis, etc., is driving the growth of the women health laboratory testing market in the United States.
Recent Developments
In November 2022, a new molecular diagnostic company, namely Roche Holdings, launched Cobas 5800 to expand access to PCR testing in the United States. The whole system unit assists in the diagnosis of infectious diseases such as HIV, human papillomavirus, syphilis, sexually transmitted diseases, etc. Additionally, in October 2019, Myriad Genetics, Inc. announced that the U.S. Food and Drug Administration (FDA) approved myChoice CDx for use as a companion diagnostic for Treatment with Zejula in late-line ovarian cancer.
Growing awareness amongst key players in the market
Several market players are getting aware of women health and diseases. Therefore, they are participating in the development of diagnostic procedures for the impressive growth of the market. Also, certain mergers and acquisitions lead to the steady growth of the market. For instance, in February 2022, Laboratory Corporation of America Holdings established a strategic partnership with Ascension to expand its testing capabilities. Additionally, in January 2022, a company, namely Your Gene Health, announced that it had signed a strategic partnership agreement with a point-of-care business, namely EKF Diagnostics Holdings plc, with accredited laboratory testing capabilities in the U.S.
Market Segmentation
United States Women Health Laboratory Testing Market can be segmented into hereditary cancer, reproductive health, and infectious diseases, prenatal screening and diagnostic testing, region, and competitive landscape. By hereditary cancer, the market can be segmented into Cervical Cancer, Ovarian Cancer, and Breast Cancer. Based on reproductive health and infectious diseases, the market can be split into CT/NG Testing, Preimplantation Genetic Testing (PGT), Herpes Simplex Virus (HSV), Hepatitis, Sexually Transmitted Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, HPV Testing. In terms of prenatal screening and diagnostic testing, the market can be segmented into Non-Invasive Prenatal Testing (NIPT), Maternal Serum Screening (MSS), and Prenatal Diagnostic Testing.
Market Players
F. Hoffmann-La Roche AG., Stanbio Laboratory L.P., Yourgene Health, Myriad Genetics Inc., Natera, Inc., Ovia Health, Laboratory Corporation of America Holdings, Inc., Gateway Genomics, LLC, Ascension Healthcare Network Inc, EKF Diagnostics Holdings Plc, etc. are some of the leading companies operating in the market.
Report Scope:
In this report, United States Women Health Laboratory Testing Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
- United States Women Health Laboratory Testing Market, By Hereditary Cancer
o Cervical Cancer
o Ovarian Cancer
o Breast Cancer
- United States Women Health Laboratory Testing Market, By Reproductive Health and Infectious Diseases
o CT/NG Testing,
o Preimplantation Genetic Testing (PGT)
o Herpes Simplex Virus (HSV)
o Hepatitis
o Sexually Transmitted Infections
o Vaginal Infections
o PAP Smear Testing
o HIV Testing
o Pregnancy and Ovulation Testing
o HPV Testing
- United States Women Health Laboratory Testing Market, By Prenatal Screening and Diagnostic Testing
o Non-Invasive Prenatal Testing (NIPT)
o Maternal Serum Screening (MSS)
o Prenatal Diagnostic Testing
- United States Women Health Laboratory Testing Market, By Region:
o Northeast
o Midwest
o South
o West
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in United States Women Health Laboratory Testing Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. United States Women Health Laboratory Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Hereditary Cancer (Cervical Cancer, Ovarian Cancer, Breast Cancer)
5.2.2. By Reproductive Health and Infectious Diseases (CT/NG Testing, Preimplantation Genetic Testing (PGT), Herpes Simplex Virus (HSV), Hepatitis, Sexually Transmitted Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, HPV Testing)
5.2.3. By Prenatal Screening and Diagnostic Testing (Non-Invasive Prenatal Testing (NIPT), Maternal Serum Screening (MSS), Prenatal Diagnostic Testing)
5.2.4. By Region (Northeast Region, Midwest Region, South Region, West Region)
5.2.5. By Company (2022)
5.3. Market Map
5.3.1. By Hereditary Cancer
5.3.2. By Reproductive Health and Infectious Diseases
5.3.3. By Prenatal Screening and Diagnostic Testing
5.3.4. By Region
6. Northeast United States Women Health Laboratory Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Hereditary Cancer
6.2.2. By Reproductive Health and Infectious Diseases
6.2.3. By Prenatal Screening and Diagnostic Testing
7. Midwest United States Women Health Laboratory Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Hereditary Cancer
7.2.2. By Reproductive Health and Infectious Diseases
7.2.3. By Prenatal Screening and Diagnostic Testing
8. South United States Women Health Laboratory Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Hereditary Cancer
8.2.2. By Reproductive Health and Infectious Diseases
8.2.3. By Prenatal Screening and Diagnostic Testing
9. West United States Women Health Laboratory Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Hereditary Cancer
9.2.2. By Reproductive Health and Infectious Diseases
9.2.3. By Prenatal Screening and Diagnostic Testing
10. Market Dynamics
10.1. Drivers
10.1.1. Prevalence of Chronic diseases
10.1.2. Recent Developments
10.1.3. Growing awareness amongst key players of the market
10.2. Challenges
10.2.1. Stringent Regulatory Guidelines Related to Laboratory Testing
10.2.2. Disparity in Awareness of Pregnancy and Fertility Issues in the Different Regions of the United States
11. Market Trends & Developments
12. United States Economic Profile
13. Competitive Landscape
13.1. Business Overview
13.2. Product Offerings
13.3. Recent Developments
13.4. Financials (In Case of Listed Companies)
13.5. Key Personnel
13.5.1. F. Hoffmann-La Roche AG.
13.5.2. Stanbio Laboratory L.P.
13.5.3. Yourgene Health
13.5.4. Myriad Genetics Inc.
13.5.5. Natera, Inc.
13.5.6. Ovia Health
13.5.7. Laboratory Corporation of America Holdings, Inc.
13.5.8. Gateway Genomics, LLC
13.5.9. Ascension Healthcare Network Inc
13.5.10. EKF Diagnostics Holdings Plc
14. Strategic Recommendations
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security